J 2020

Autoimmune pancreatitis - An ongoing challenge

BLAHO, Martin, Petr DÍTĚ, Lumír KUNOVSKÝ and Bohuslav KIANIČKA

Basic information

Original name

Autoimmune pancreatitis - An ongoing challenge

Authors

BLAHO, Martin (203 Czech Republic), Petr DÍTĚ (203 Czech Republic), Lumír KUNOVSKÝ (203 Czech Republic, belonging to the institution) and Bohuslav KIANIČKA (203 Czech Republic, guarantor, belonging to the institution)

Edition

Advances in Medical Sciences, Bialystok, Medical Univ Bialystok, 2020, 1896-1126

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30219 Gastroenterology and hepatology

Country of publisher

Poland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 3.287

RIV identification code

RIV/00216224:14110/20:00116220

Organization unit

Faculty of Medicine

UT WoS

000613505100022

Keywords in English

Autoimmune pancreatitis; Chronic pancreatitis; IgG4-related disease; Pancreatic insufficiency; Pancreatic cancer

Tags

International impact, Reviewed
Změněno: 4/2/2021 11:12, Mgr. Tereza Miškechová

Abstract

V originále

Autoimmune pancreatitis is a rare form of chronic pancreatitis. The first descriptions of the disease date back to the 1990s. Etiology is multifactorial, with the use of genetic, environmental and complex immunological mechanisms. It is classified into two subtypes. Type 1 is part of a group of diseases called IgG4-related disease. Clinically is autoimmune pancreatitis manifested by icterus and abdominal discomfort. It can rarely present as acute pancreatitis. There is also a completely asymptomatic form of the disease. The diagnosis is based on abnormalities in histology, imaging methods, serology, the involvement of other organs in relation to IgG4-related disease, and a significant positive response to corticosteroid therapy. Differential diagnosis between the focal form of autoimmune pancreatitis and pancreatic cancer can be complicated, with endosonography playing an important role. In the treatment, we use corticosteroids and other immunosuppressants including biological therapy. Patients with the asymptomatic disease should also be treated to prevent late complications and exocrine and endocrine insufficiency. In addition to drug treatment, endoscopic and/or surgical treatment may be necessary. Even after recovery, the disease can relapse. The relationship between autoimmune pancreatitis and malignancies has not been clearly confirmed. The goal of this review is to provide a comprehensive look at autoimmune pancreatitis and translate latest scientific knowledge into clinical practice.